P
Public Health Emergency Medical Countermeasures Enterprise
Washington D.C.
Overview
The Public Health Emergency Medical Countermeasures Enterprise (PHEMCE) is an interagency U.S. government partnership that funds and coordinates the development, acquisition, and stockpiling of medical countermeasures, including vaccines, drugs, and diagnostics, to address public health emergencies.
Year Founded
2006
Portfolio Companies
90
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Inso Biosciences | Jun 2026 | Grant | Co-investor |
| Prenosis | Jan 2026 | Grant | Co-investor |
| Locus Biosciences | Jan 2026 | Grant | Co-investor |
| Macro Biologics | Dec 2025 | Grant | Co-investor |
| NeuImmune, Inc. | Dec 2025 | Corporate Funding | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
